Literature DB >> 23589123

Cerebral toxoplasmosis after rituximab therapy.

Gilles Safa, Laure Darrieux.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23589123     DOI: 10.1001/jamainternmed.2013.374

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  12 in total

Review 1.  COVID-19-associated opportunistic infections: a snapshot on the current reports.

Authors:  Amir Abdoli; Shahab Falahi; Azra Kenarkoohi
Journal:  Clin Exp Med       Date:  2021-08-23       Impact factor: 5.057

Review 2.  Rituximab associated late-onset neutropenia-a rheumatology case series and review of the literature.

Authors:  William E Monaco; Jonathan D Jones; William F C Rigby
Journal:  Clin Rheumatol       Date:  2016-05-21       Impact factor: 2.980

Review 3.  Fulminant hepatitis due to human adenovirus.

Authors:  B A Ronan; N Agrwal; E J Carey; G De Petris; S Kusne; M T Seville; J E Blair; H R Vikram
Journal:  Infection       Date:  2013-08-24       Impact factor: 3.553

4.  Toxoplasmic encephalitis during mycophenolate mofetil immunotherapy of neuromuscular disease.

Authors:  Danilo R Bernardo; Nizar Chahin
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-01-22

5.  Brain abscess following rituximab infusion in a patient with pemphigus vulgaris.

Authors:  Talal M Al-Harbi; Shahad A Al-Muammar; Ronald J Ellis
Journal:  Am J Case Rep       Date:  2015-02-07

6.  Cerebral toxoplasmosis in a diffuse large B cell lymphoma patient.

Authors:  Lina Savsek; Tanja Ros Opaskar
Journal:  Radiol Oncol       Date:  2016-02-16       Impact factor: 2.991

7.  Acute Toxoplasma Dissemination With Encephalitis in the Era of Biological Therapies.

Authors:  Amal A Gharamti; Amy Rao; Paula E Pecen; Andrés F Henao-Martínez; Carlos Franco-Paredes; José G Montoya
Journal:  Open Forum Infect Dis       Date:  2018-10-17       Impact factor: 3.835

8.  Toxoplasma Encephalitis in Atypical Hosts at an Academic Cancer Center.

Authors:  Sejal Morjaria; David J Epstein; Fabian A Romero; Ying Taur; Susan K Seo; Genovefa A Papanicolaou; Vaios Hatzoglou; Marc Rosenblum; Miguel-Angel Perales; Michael Scordo; Anna Kaltsas
Journal:  Open Forum Infect Dis       Date:  2016-03-30       Impact factor: 3.835

9.  Central Nervous System Toxoplasmosis in Relapsed Hodgkin's Lymphoma: A Case Report.

Authors:  Hassan Abolghasemi; Ehsan Shahverdi; Ramezan Jafari; Fardin Dolatimehr; Azam Khandani
Journal:  Iran J Cancer Prev       Date:  2016-06-11

10.  Cerebral toxoplasmosis after rituximab for pemphigus vulgaris.

Authors:  Erica B Lee; Noura Ayoubi; Mehmet Albayram; Vidhu Kariyawasam; Kiran Motaparthi
Journal:  JAAD Case Rep       Date:  2019-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.